We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+3.41%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$440M
AUM Growth
+$88K
(+0.02%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
138
New
1
Increased
40
Reduced
70
Closed
8
Avg Time Held
1.9
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.87M |
| 2 |
S&P Global
SPGI
|
+$2.66M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$342K |
| 4 |
PPG Industries
PPG
|
+$273K |
| 5 |
Bank of America
BAC
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$8.4M |
| 2 |
Danaher
DHR
|
+$2.62M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$2.45M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$925K |
| 5 |
Lockheed Martin
LMT
|
+$641K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.54% |
| 2 | Industrials | 16.46% |
| 3 | Consumer Staples | 13.52% |
| 4 | Technology | 13.01% |
| 5 | Financials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$4.01T
| $13M | 2.96% |
254,661
-8,003
| -3% | -$416K |
2013 Q2
12 quarters
|
|
|
2
Lockheed Martin
LMT
$123B
| $12.4M | 2.82% |
50,067
-2,719
| -5% | -$641K |
2013 Q2
12 quarters
|
|
3
Altria Group
MO
$123B
| $11.8M | 2.68% |
170,849
-8,964
| -5% | -$574K |
2013 Q2
12 quarters
|
|
4
Johnson & Johnson
JNJ
$610B
| $11.8M | 2.67% |
96,889
-3,535
| -4% | -$402K |
2013 Q2
12 quarters
|
|
5
Honeywell
HON
$66.7B
| $10.7M | 2.43% |
102,099
-4,533
| -4% | -$466K |
2013 Q2
12 quarters
|
|
|
6
Pfizer
PFE
$168B
| $10.5M | 2.38% |
313,973
+246,738
| +367% | +$7.87M |
2013 Q2
12 quarters
|
|
7
DuPont de Nemours
DD
$17.8B
| $10.3M | 2.35% |
82,127
-632
| -0.8% | -$83.1K |
2013 Q4
10 quarters
|
|
8
Merck
MRK
$358B
| $10.1M | 2.3% |
184,084
-3,044
| -2% | -$162K |
2013 Q2
12 quarters
|
|
9
JPMorgan Chase
JPM
$891B
| $9.75M | 2.22% |
156,907
-1,016
| -0.6% | -$63.5K |
2013 Q2
12 quarters
|
|
10
Cisco
CSCO
$433B
| $9.75M | 2.22% |
339,746
-9,735
| -3% | -$273K |
2013 Q2
12 quarters
|
|
11
United Parcel Service
UPS
$83.2B
| $9.62M | 2.19% |
89,293
-622
| -0.7% | -$64.7K |
2013 Q4
10 quarters
|
|
|
12
Bristol-Myers Squibb
BMY
$124B
| $9.56M | 2.17% |
129,945
-13,096
| -9% | -$925K |
2013 Q2
12 quarters
|
|
13
Procter & Gamble
PG
$365B
| $9.53M | 2.17% |
112,550
-2,193
| -2% | -$180K |
2013 Q2
12 quarters
|
|
14
Walt Disney
DIS
$191B
| $9.51M | 2.16% |
97,237
-1,921
| -2% | -$192K |
2013 Q2
12 quarters
|
|
15
Oracle
ORCL
$408B
| $9.45M | 2.15% |
230,934
-5,651
| -2% | -$226K |
2013 Q2
12 quarters
|
|
16
CVS Health
CVS
$118B
| $9.33M | 2.12% |
97,419
-3,327
| -3% | -$332K |
2013 Q2
12 quarters
|
|
17
American International
AIG
$41.4B
| $9.1M | 2.07% |
172,082
-1,420
| -0.8% | -$78.4K |
2014 Q1
9 quarters
|
|
18
Diageo
DEO
$52.3B
| $8.93M | 2.03% |
79,116
+117
| +0.1% | +$12.7K |
2015 Q3
3 quarters
|
|
19
General Dynamics
GD
$91.2B
| $8.78M | 2% |
63,052
+195
| +0.3% | +$27.2K |
2015 Q4
2 quarters
|
|
20
Loews
L
$22.2B
| $8.73M | 1.98% |
212,442
-3,661
| -2% | -$145K |
2013 Q2
12 quarters
|
|
|
RDS.A
21
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $8.56M | 1.95% |
163,558
+7,090
| +5% | +$342K |
2013 Q2
12 quarters
|
|
22
Ford
F
$49.1B
| $8M | 1.82% |
636,635
-2,135
| -0.3% | -$28.1K |
2013 Q4
10 quarters
|
|
23
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $7.89M | 1.79% |
157,031
+1,686
| +1% | +$89.8K |
2013 Q2
12 quarters
|
|
|
BHI
24
DELISTED
Baker Hughes
BHI
| $6.64M | 1.51% |
147,103
+2,903
| +2% | +$131K |
2013 Q2
12 quarters
|
|
25
Fluor
FLR
$6.38B
| $6.41M | 1.46% |
130,067
+800
| +0.6% | +$41.6K |
2013 Q2
12 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q2 2016 Portfolio in Review
As of Q2 2016, Strategy Asset Managers held 138 positions worth $440M, up 0.02% from $440M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Strategy Asset Managers's Q2 2016 filing shows 1 new, 40 increased, 70 reduced and 8 closed positions. Its largest new stake was S&P Global: 24,745 shares worth $2.65M. The largest sale was EMC CORPORATION, an estimated $8.4M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.
- Strategy Asset Managers's largest Q2 2016 buy was S&P Global: 24,745 shares worth $2.65M.
- Strategy Asset Managers added most to Pfizer in Q2 2016, an estimated $7.87M increase.
- Strategy Asset Managers's biggest Q2 2016 reduction was EMC CORPORATION, cutting an estimated $8.4M.
- Strategy Asset Managers fully exited Danaher in Q2 2016, selling an estimated $2.62M.
- Strategy Asset Managers's ten largest holdings make up 25% of its $440M portfolio in Q2 2016.
- Strategy Asset Managers opened 1 new position and closed 8 in Q2 2016.
- Strategy Asset Managers's portfolio value rose 0.02% quarter-over-quarter to $440M.
Based on Strategy Asset Managers's 13F filing for Q2 2016, filed 4 Aug 2016.